Inventor
THEDE KAI
DE34 patents
⚠️ This page may combine multiple inventors who share the name “THEDE KAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
9 patentsUS10981932B2Apr 20, 2021
Macrocyclic indole derivatives
BAYER AG9 citations83
US11492358B1Nov 8, 2022
Macrocyclic indole derivatives
BAYER AG3 citations71
US11478451B1Oct 25, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11447504B2Sep 20, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11440923B2Sep 13, 2022
Substituted macrocyclic indole derivatives
BAYER AG3 citations71
US10968216B2Apr 6, 2021
4,5-annulated 1,2,4-triazolones
BAYER AG3 citations70
US11891404B2Feb 6, 2024
Substituted macrocyclic indole derivatives
BAYER AG1 citations61
US11787797B2Oct 17, 2023
4,5-annulated 1,2,4-triazolones
BAYER AG0 citations59
US11161825B2Nov 2, 2021
4-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-carboxamides
BAYER AG0 citations47
THEDE KAI
8 patentsUS8653111B2Feb 18, 2014
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
THEDE KAI7 citations83
US8389520B2Mar 5, 2013
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
THEDE KAI8 citations83
US8524699B2Sep 3, 2013
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors
THEDE KAI6 citations72
US8609698B2Dec 17, 2013
Substituted dipyridyl-dihydropyrazolones and use thereof
THEDE KAI4 citations61
US8399682B2Mar 19, 2013
Substituted (pyrazolylcarbonyl)imidazolidinones and their use
THEDE KAI2 citations59
US8324268B2Dec 4, 2012
Substituted furancarboxamides, and use thereof
THEDE KAI1 citations49
US8575357B2Nov 5, 2013
Substituted (thiazolyl-carbonyl)imidazolidinones and use thereof
THEDE KAI0 citations38
US8546438B2Oct 1, 2013
Substituted (thiophenyl-carbonyl)imidazolidinones, and use thereof
THEDE KAI0 citations38
BROAD INST INC
4 patentsUS11401278B2Aug 2, 2022
Macrocyclic indole derivatives
BROAD INST INC3 citations71
US11286263B2Mar 29, 2022
Macrocyclic fluorine substituted indole derivatives
BROAD INST INC3 citations71
US12152041B2Nov 26, 2024
Macrocyclic fluorine substituted indole derivatives
BROAD INST INC1 citations61
US12338250B2Jun 24, 2025
Methods of preparing macrocyclic indoles
BROAD INST INC0 citations49
LIU NINGSHU
3 patentsUS9278925B2Mar 8, 2016
Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
LIU NINGSHU3 citations71
US9000026B2Apr 7, 2015
Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3-en-2-ones for therapy
LIU NINGSHU2 citations61
US9212140B2Dec 15, 2015
(5s,8s)-3-(4′-chlor-3′-fluor-4-methlybiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5] dec-3-en-2-one (compound A) for treatment
LIU NINGSHU0 citations49
AICURIS GMBH & CO KG
3 patentsFLAMME INGO
2 patentsUS8252817B2Aug 28, 2012
Dipyridyl-dihydropyrazolones and their use
FLAMME INGO7 citations81
US9085572B2Jul 21, 2015
4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases
FLAMME INGO1 citations46